Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.905 SEK | -2.35% | -0.17% | -62.08% |
Apr. 15 | Oncopeptides AB Secures National Reimbursement for Pepaxti in Spain | CI |
Apr. 04 | Oncopeptides AB Provides Sales Guidance for the First Quarter of 2024 | CI |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
58.44M | - | |||||
108B | ||||||
105B | ||||||
23.46B | - | |||||
21.72B | - | |||||
18.64B |
- Stock Market
- Equities
- ONCO Stock
- Charts Oncopeptides AB
- Sector Chart